Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Filament Health Corp FLHLF


Primary Symbol: N.FH

Filament Health Corp. is a Canada-based clinical-stage natural psychedelic drug development company. The Company’s platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The Company’s first three botanical drug candidates are standardized, purified extracts of psilocybe cubensis fruiting bodies include: PEX010 Psilocybin ... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NEO:FH)

FILAMENT HEALTH TO DISCUSS ITS DRUG DEVELOPMENT PLATFORM IN FIRESIDE CHAT WITH WATER TOWER RESEARCH ON APRIL 4, 2024 AT 12PM ET

Canada NewsWire April 3, 2024

FILAMENT HEALTH REPORTS Q4 AND YEAR END 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Canada NewsWire April 2, 2024

FILAMENT HEALTH ANNOUNCES APPOINTMENT OF MICHAEL MESSINGER TO ITS BOARD OF DIRECTORS

Canada NewsWire March 28, 2024

FILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL INVESTIGATION

Canada NewsWire March 19, 2024

FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO ISRAEL

Canada NewsWire February 15, 2024

FDA investigating new psychedelic drug to treat substance abuse

Jonathon Brown January 31, 2024

FILAMENT HEALTH ANNOUNCES FDA OPENING OF INVESTIGATIONAL NEW DRUG APPLICATION FOR SUBSTANCE USE DISORDERS

Canada NewsWire January 31, 2024

FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO AUSTRALIA

Canada NewsWire January 17, 2024

FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS

Canada NewsWire January 2, 2024
View More News ››

Opinion & Analysis (NEO:FH)

Unlocking the Healing Potential of Safe, Natural Psychedelics

Dave Jackson April 12, 2022

Opportunity Knocks as the Door Opens to Naturally-Derived Psychedelics

Dave Jackson July 14, 2021
View More Opinion ››

Bullboard Posts (NEO:FH)

Deal

I am one happy camper that this deal did not go through.  It was bad from the get go. What has not been reported is what the cost...
fossil8 - January 2, 2024

Jupiter redemptions

Jupiter had $160 million cash at March 31, 2023 and $15 million at June 30, 2023
lscfa - September 27, 2023

RE:1-for-10 rollback

Jupiter has $217 mil Cdn cash & securities but assuming 90% redemptions and $13.3 mil transaction costs so only $7 mil cdn cash after...
lscfa - August 15, 2023

1-for-10 rollback

Filament shareholders only get 20,600,000 shares in merged co. This is 1/10 of FH shares o/s.      https://www...
lscfa - August 15, 2023

Patience Required

This stock is going to rock especially with the new alliance. Doors will open now and funds will be available.  Got a dream team...
fossil8 - August 8, 2023

FILAMENT HEALTH ENTERS EXCLUSIVE LICENSING AGREEMENT

NeoLumina's license for Filament's botanical psilocybin drug candidate provides exclusive global right to clinical and...
Betteryear2 - June 30, 2023
View more Bullboard ››

Lode Gold Resources Inc

Lode Gold Resources Inc

Lode Gold Resources Inc. is a Canadian exploration and development company with grassroots and advanced exploration ...
View More »